Fakultni nemocnice Olomouc FNOL

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Acute myeloid leukaemia1 trial
• Diffuse large B-cell lymphoma1 trial
• Follicular lymphoma1 trial
• Hodgkin lymphoma1 trial
• Lung cancer1 trial
• Melanoma1 trial
• Multiple myeloma1 trial
• Myelodysplastic syndromes1 trial

Phase

• Phase 32 trials

Status

• Recruiting3 trials

Lead sponsor

• Immunocore Ltd1 trial
• JaxBio Ltd1 trial
• NovoCure GmbH1 trial

Running trials

• Recruiting

  LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

  NCT06216301· Phase 3· NovoCure GmbH· Source

  Contact: Bohuslav Melichar

• Recruiting

  IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

  NCT06112314· Phase 3· Immunocore Ltd· Source

  Contact: Bohuslav Melichar

• Recruiting

  Early Detection and Screening of Hematological Malignancies - SANGUINE

  NCT05735704· JaxBio Ltd· Source

  Contact: Tomáš Papajík, Prof., MD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute myeloid leukaemia1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Follicular lymphoma1 recruiting
• Hodgkin lymphoma1 recruiting
• Lung cancer1 recruiting
• Melanoma1 recruiting
• Multiple myeloma1 recruiting
• Myelodysplastic syndromes1 recruiting